Ivy Saha, Jitu Halder, Tushar Kanti Rajwar, Ritu Mahanty, Deepak Pradhan, Priyanka Dash, Chandan Das, Vineet Kumar Rai, Biswakanth Kar, Goutam Ghosh, Goutam Rath
Cervical cancer (CC) is the fourth leading cancer type in females globally. Being an ailment of the birth canal, primitive treatment strategies, including surgery, radiation, or laser therapy, bring along the risk of infertility, neonate mortality, premature parturition, etc. Systemic chemotherapy led to systemic toxicity. Therefore, delivering a smaller cargo of therapeutics to the local site is more beneficial in terms of efficacy as well as safety. Due to the regeneration of cervicovaginal mucus, conventional dosage forms come with the limitations of leaking, the requirement of repeated administration, and compromised vaginal retention...
April 11, 2024: AAPS PharmSciTech